Design Therapeutics DSGN
NASDAQ DSGN
$12.60 -0.02 (-0.16%)
As of: Sep 30, 2026 · 1:33 PM EDT

Design Therapeutics, Inc. (DSGN) EBT Margin (2020)

Updated

Design Therapeutics' EBT Margin was -11700.00% in Q4 2020, up 215.00 percentage points from the prior quarter.

Analysis

Design Therapeutics, Inc. (DSGN) EBT Margin (2020) Analysis & Trends

For FY2020, EBT Margin at Design Therapeutics came in at -3685.84%.

  • Quarterly EBT Margin has moved between -11915.00% (Q3 2020) and -438.73% (Q1 2020) over five years.
  • Per Business Quant data, DSGN's EBT Margin in the three quarters before Q4 2020 was -11915.00% (Q3 2020), -4719.35% (Q2 2020) and -438.73% (Q1 2020).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 -11,700.00%
Sep 30, 2020 -11,915.00%
Jun 30, 2020 -4,719.35%
Mar 31, 2020 -438.73%
API Access

Design Therapeutics, Inc. EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=DSGN&period=max&api_key=YOUR_API_KEY